APA aipamena

Offin, M., Chan, J. M., Tenet, M., Rizvi, H. A., Shen, R., Riely, G. J., . . . Yu, H. A. (2019). Concurrent RB1 and TP53 alterations define a subset of EGFR-mutant lung cancers at risk for histologic transformation and inferior clinical outcomes. J Thorac Oncol.

Chicago Style aipamena

Offin, Michael, et al. "Concurrent RB1 and TP53 Alterations Define a Subset of EGFR-mutant Lung Cancers At Risk for Histologic Transformation and Inferior Clinical Outcomes." J Thorac Oncol 2019.

MLA aipamena

Offin, Michael, et al. "Concurrent RB1 and TP53 Alterations Define a Subset of EGFR-mutant Lung Cancers At Risk for Histologic Transformation and Inferior Clinical Outcomes." J Thorac Oncol 2019.